Histamine h3 Non imidazole aryl alkylamines compounds are receptor antagonists, their preparation and therapeutic uses

Formula I The present invention illustrating the selective antagonism to histamine H3 receptor: [Formula 1] In novel substituted arylalkylamine compound or salt is a pharmaceutically acceptable and represented discloses a process for preparing this compound. In another aspect, the present invention discloses methods of using them to treat pharmaceutical compositions and obesity and other histamine H3 receptor-related diseases including cyclic amines.